{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:54:27Z","timestamp":1789786467632,"version":"4.0.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u00c5land cultural foundation"},{"name":"Selander foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193492","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T19:22:50Z","timestamp":1519413770000},"page":"e0193492","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2576-9938","authenticated-orcid":true,"given":"Valter","family":"Niemel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Sundblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci7060067","article-title":"Neuropsychiatric Burden in Huntington's Disease","volume":"7","author":"RA Paoli","year":"2017","journal-title":"Brain Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cortex.2017.07.017","article-title":"Cognitive decline in Huntington's disease expansion gene carriers","volume":"95","author":"V Baake","year":"2017","journal-title":"Cortex"},{"key":"ref4","article-title":"Huntington's disease: a clinical review","author":"P McColgan","year":"2017","journal-title":"European journal of neurology"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"M Bjorkqvist","year":"2008","journal-title":"The Journal of experimental medicine"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"YF Tai","year":"2007","journal-title":"Brain: a journal of neurology"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1172\/JCI64565","article-title":"Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression","volume":"122","author":"A Weiss","year":"2012","journal-title":"The Journal of clinical investigation"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"A Crotti","year":"2015","journal-title":"Trends Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","article-title":"Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers","volume":"83","author":"M Politis","year":"2015","journal-title":"Neurobiology of disease"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-160196","article-title":"Cerebrospinal Fluid Biomarkers for Huntington's Disease","volume":"5","author":"LM Byrne","year":"2016","journal-title":"Journal of Huntington's disease"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"e0172762","DOI":"10.1371\/journal.pone.0172762","article-title":"Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?","volume":"12","author":"V Niemela","year":"2017","journal-title":"PloS one"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2008.05.012","article-title":"Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease","volume":"15","author":"R Constantinescu","year":"2009","journal-title":"Parkinsonism & related disorders"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients","volume":"125","author":"EJ Wild","year":"2015","journal-title":"The Journal of clinical investigation"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1212\/NXI.0000000000000287","article-title":"Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease","volume":"3","author":"T Vinther-Jensen","year":"2016","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.parkreldis.2011.06.010","article-title":"Increased levels of total tau protein in the cerebrospinal fluid in Huntington's disease","volume":"17","author":"R Constantinescu","year":"2011","journal-title":"Parkinsonism & related disorders"},{"key":"ref16","article-title":"Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease","author":"FB Rodrigues","year":"2016","journal-title":"Journal of neurochemistry"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/nan.12378","article-title":"Review: Tau in biofluids\u2014relation to pathology, imaging and clinical features","volume":"43","author":"H Zetterberg","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","article-title":"In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases","volume":"7","author":"D Bonneh-Barkay","year":"2010","journal-title":"J Neuroinflammation"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","article-title":"Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation","volume":"22","author":"D Bonneh-Barkay","year":"2012","journal-title":"Brain Pathol"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"e0163479","DOI":"10.1371\/journal.pone.0163479","article-title":"Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease","volume":"11","author":"FB Rodrigues","year":"2016","journal-title":"PloS one"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.24408","article-title":"Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis","volume":"78","author":"M Komori","year":"2015","journal-title":"Annals of neurology"},{"key":"ref22","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis","author":"LM Byrne","year":"2017","journal-title":"The Lancet Neurology"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/mds.26011","article-title":"Diagnostic criteria for Huntington's disease based on natural history","volume":"29","author":"R Reilmann","year":"2014","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.29.1.1","article-title":"Huntington disease: clinical care and evaluation","volume":"29","author":"I Shoulson","year":"1979","journal-title":"Neurology"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in Huntington's disease","volume":"41","author":"JB Penney Jr.","year":"1997","journal-title":"Annals of neurology"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length","volume":"65","author":"DR Langbehn","year":"2004","journal-title":"Clinical genetics"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.parkreldis.2014.08.011","article-title":"YKL-40 in cerebrospinal fluid in Huntington's disease\u2014a role in pathology or a nonspecific response to inflammation?","volume":"20","author":"T Vinther-Jensen","year":"2014","journal-title":"Parkinsonism & related disorders"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus","volume":"50","author":"RH Myers","year":"1991","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice","volume":"17","author":"X Tong","year":"2014","journal-title":"Nat Neurosci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T14:22:15Z","timestamp":1719843735000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193492"}},"subtitle":[],"editor":[{"given":"Ramon","family":"Trullas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193492","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]}}}